Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)
China
· Delayed Price · Currency is CNY 15.97
+0.31 (1.98%)
Apr 30, 2025, 3:04 PM CST
SHE:000623 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 2,298 | 2,537 | 3,404 | 2,850 | 2,263 | 2,237 | Upgrade
|
| Other Revenue | 73.86 | 73.86 | 45.58 | 17.95 | 41.05 | 15.11 | Upgrade
|
| Revenue | 2,372 | 2,611 | 3,449 | 2,868 | 2,304 | 2,252 | Upgrade
|
| Revenue Growth (YoY) | -32.67% | -24.31% | 20.25% | 24.50% | 2.31% | -27.09% | Upgrade
|
| Cost of Revenue | 1,402 | 1,602 | 1,768 | 1,417 | 1,111 | 929.01 | Upgrade
|
| Gross Profit | 969.45 | 1,008 | 1,681 | 1,451 | 1,193 | 1,323 | Upgrade
|
| Selling, General & Admin | 1,081 | 1,055 | 1,354 | 1,181 | 1,093 | 1,279 | Upgrade
|
| Research & Development | 76.38 | 82.2 | 124.98 | 85.68 | 49.42 | 67.21 | Upgrade
|
| Other Operating Expenses | 37.85 | 37.28 | 46.43 | 42.77 | 39.3 | 43.02 | Upgrade
|
| Operating Expenses | 1,181 | 1,169 | 1,546 | 1,321 | 1,187 | 1,388 | Upgrade
|
| Operating Income | -211.66 | -160.4 | 134.53 | 129.91 | 5.87 | -65.74 | Upgrade
|
| Interest Expense | -54.09 | -92.08 | -144.35 | -142.99 | -130.49 | -126.82 | Upgrade
|
| Interest & Investment Income | 2,117 | 1,877 | 1,382 | 1,697 | 2,070 | 1,916 | Upgrade
|
| Other Non Operating Income (Expenses) | -3.37 | 7.42 | 107.65 | 589.79 | -7.62 | -5.28 | Upgrade
|
| EBT Excluding Unusual Items | 1,848 | 1,632 | 1,479 | 2,274 | 1,937 | 1,718 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -24.28 | Upgrade
|
| Gain (Loss) on Sale of Investments | 88.27 | -121.67 | -111.06 | -632.66 | -259.53 | -75.98 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.64 | -0.67 | 36.16 | 3.16 | -0.94 | -0.64 | Upgrade
|
| Asset Writedown | -65.34 | -65.33 | -3.25 | -1.25 | -2.84 | -1.25 | Upgrade
|
| Other Unusual Items | 77.54 | 77.54 | 98.83 | 77.92 | 92.6 | 100.79 | Upgrade
|
| Pretax Income | 1,948 | 1,521 | 1,500 | 1,721 | 1,767 | 1,717 | Upgrade
|
| Income Tax Expense | 44.73 | 2.23 | 55.83 | -80.16 | -4.19 | 25.14 | Upgrade
|
| Earnings From Continuing Operations | 1,903 | 1,519 | 1,444 | 1,801 | 1,771 | 1,691 | Upgrade
|
| Minority Interest in Earnings | 21.52 | 32.2 | 15.54 | -20.2 | 9.64 | 17.46 | Upgrade
|
| Net Income | 1,925 | 1,551 | 1,460 | 1,781 | 1,781 | 1,709 | Upgrade
|
| Net Income to Common | 1,925 | 1,551 | 1,460 | 1,781 | 1,781 | 1,709 | Upgrade
|
| Net Income Growth | 72.18% | 6.27% | -18.02% | 0.02% | 4.19% | 21.75% | Upgrade
|
| Shares Outstanding (Basic) | 1,190 | 1,177 | 1,125 | 1,135 | 1,139 | 1,158 | Upgrade
|
| Shares Outstanding (Diluted) | 1,190 | 1,177 | 1,295 | 1,301 | 1,259 | 1,276 | Upgrade
|
| Shares Change (YoY) | -6.51% | -9.08% | -0.46% | 3.36% | -1.39% | -0.28% | Upgrade
|
| EPS (Basic) | 1.62 | 1.32 | 1.30 | 1.57 | 1.56 | 1.48 | Upgrade
|
| EPS (Diluted) | 1.62 | 1.32 | 1.23 | 1.47 | 1.51 | 1.43 | Upgrade
|
| EPS Growth | 65.11% | 7.39% | -16.35% | -2.93% | 5.70% | 20.92% | Upgrade
|
| Free Cash Flow | -103.17 | -214.5 | -351.46 | 152.89 | 11.54 | 163.02 | Upgrade
|
| Free Cash Flow Per Share | -0.09 | -0.18 | -0.27 | 0.12 | 0.01 | 0.13 | Upgrade
|
| Dividend Per Share | 0.500 | 0.500 | 0.600 | 0.300 | 0.300 | 0.200 | Upgrade
|
| Dividend Growth | -16.67% | -16.67% | 100.00% | - | 50.00% | - | Upgrade
|
| Gross Margin | 40.87% | 38.62% | 48.74% | 50.59% | 51.76% | 58.74% | Upgrade
|
| Operating Margin | -8.92% | -6.14% | 3.90% | 4.53% | 0.26% | -2.92% | Upgrade
|
| Profit Margin | 81.14% | 59.43% | 42.33% | 62.09% | 77.29% | 75.89% | Upgrade
|
| Free Cash Flow Margin | -4.35% | -8.22% | -10.19% | 5.33% | 0.50% | 7.24% | Upgrade
|
| EBITDA | -5.64 | 45.48 | 339.83 | 326.49 | 200.39 | 129.73 | Upgrade
|
| EBITDA Margin | -0.24% | 1.74% | 9.85% | 11.38% | 8.70% | 5.76% | Upgrade
|
| D&A For EBITDA | 206.02 | 205.88 | 205.3 | 196.58 | 194.53 | 195.46 | Upgrade
|
| EBIT | -211.66 | -160.4 | 134.53 | 129.91 | 5.87 | -65.74 | Upgrade
|
| EBIT Margin | -8.92% | -6.14% | 3.90% | 4.53% | 0.26% | -2.92% | Upgrade
|
| Effective Tax Rate | 2.30% | 0.15% | 3.72% | - | - | 1.47% | Upgrade
|
| Revenue as Reported | 2,372 | 2,611 | 3,449 | 2,868 | 2,304 | 2,252 | Upgrade
|
| Advertising Expenses | - | 183.98 | 277.99 | 202.59 | 160.73 | 212.53 | Upgrade
|
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.